Anaesthesia with remifentanil and rocnroninm for caesarean section in a patient with long-QT syndrome and an automatic implantable cardioverter-defibrillator

International Journal of Obstetric Anesthesia

Volumn 9, Issue 2, 2000, Pages 133-136

  Johnston, A J ^a   Hall, J M ^a   Levy, D M ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; ISOFLURANE; NARCOTIC ANALGESIC AGENT; NEUROMUSCULAR BLOCKING AGENT; NITROUS OXIDE; REMIFENTANIL; ROCURONIUM; THIOPENTAL;

ADULT; ANESTHESIA INDUCTION; ARTICLE; ARTIFICIAL HEART PACEMAKER; AUTOMATIC CARDIOVERSION; CATECHOLAMINE BLOOD LEVEL; CESAREAN SECTION; CLINICAL ARTICLE; DRUG CHOICE; FEMALE; GENERAL ANESTHESIA; GESTATIONAL AGE; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG QT SYNDROME; MORTALITY; PATHOPHYSIOLOGY; RISK;

EID: 0034067857     PISSN: 0959289X     EISSN: None     Source Type: Journal    
DOI: 10.1054/ijoa.1999.0362     Document Type: Article

References (19)

1. Zareba W., Moss A. J., Schwartz P. J. Influence of the genotype on the clinical course of the long-QT syndrome. N Engl J Med. 339:1998;960-965.
2. Wig J., Bali I. M., Singh R. G., Kataria R. N., Khattri H. N. Long Q-T interval syndrome. Sudden cardiac arrest during anaesthesia. Anaesthesia. 34:1979;37-40.
3. Medak R., Benumof J. L. Perioperative management of the long Q-T interval syndrome. Br J Anaesth. 55:1983;361-364.
4. Nagakura S., Shirai Y., Yamai K., Hatakeyama K. Sudden perioperative death in an adult with undiagnosed Jervell and Lange-Nielsen syndrome. Surgery. 122:1997;645-646.
5. Swenerton J. E., Huckell V. F. Disorders of cardiac conduction. Gambling D. R., Douglas J. M., Obstetric Anaesthesia and Uncommon Disorders. 1998;39-49 Saunders, Philadelphia.
6. Roden D. M., Lazzara R., Rosen M., Schwartz P. J., Towbin J., Vincent M. Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. Circulation. 94:1996;1996-2012.
7. Groh W. J., Silka M. J., Oliver R. P., Halperin B. D., McAnulty J. H., Kron J. Use of implantable cardioverter defibrillators in the congenital long QT syndrome. Am J Cardiol. 78:1996;703-706.
8. Kam P. C. A. Anaesthetic management of a patient with an automatic implantable cardioverter defrillator in situ. Br J Anaesth. 78:1997;102-106.
9. Higgin G. L. The automatic implantable defibrillator: management issues relevent to the emergency care provider. Am J Emerg Med. 8:1990;342-347.
10. Ryan H. Anaesthesia for caesarean section in a patient with Jervell, Lange-Nielsen syndrome. Can J Anaesth. 35:1988;422-444.
11. Shnider S. M., Abboud T. K., Artal R., Henriksen E. H., Stefani S. J., Levinson G. Maternal catecholamines decrease during labor after epidural anesthesia. Am J Obstet Gynecol. 147:1983;13-15.
12. Kinsella S. M., Norris M. C. Advance prediction of hypotension at caesarean delivery under spinal anaesthesia. International Journal of Obstetric Anesthesia. 5:1996;3-7.
13. Michaloudis D., Fraidakis O., Petrou A., Gigourtsi C., Parthenakis F. Anaesthesia and the QT interval. Effects of isoflurane and halothane in unpremedicated children. Anaesthesia. 53:1998;435-439.
14. Finfer S. R. Pacemaker failure on induction of anaesthesia. Br J Anaesth. 66:1991;509-512.
15. Galloway P. A., Glass P. S. A. Anesthetic implications of long QT interval syndromes. Anesth Analg. 64:1985;612-620.
16. Batson M. A., Longmire S., Csontos E. Alfentanil for urgent caesarean section in a patient with severe mitral stenosis and pulmonary hypertension. Can J Anaesth. 37:1990;685-688.
17. Duthie D. J. R. Remifentanil and tramadol. Br J Anaesth. 81:1998;51-57.
18. Kan R. E., Hughes S. C., Rosen M. A., Kessin C., Preston P. G., Lobo E. P. Intravenous remifentanil: placental transfer, maternal and neonatal effects. Anesthesiology. 98:1998;1467-1474.
19. Scott H., Bateman C., Price M. The use of remifentanil in general anaesthesia for Caesarean section in a patient with mitral valve disease. Anaesthesia. 53:1998;695-697.